These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6262021)

  • 1. Assay of cefotaxime by high-pressure-liquid chromatography.
    Bergan T; Solberg R
    Chemotherapy; 1981; 27(3):155-65. PubMed ID: 6262021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of microbiological and high pressure liquid chromatographic assays of the new cephalosporin cefroxadine.
    Bergan T; Solberg R
    Methods Find Exp Clin Pharmacol; 1981; 3(3):179-82. PubMed ID: 7253774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative determination of cefotaxime and desacetyl cefotaxime in serum and bile by bioassay and high-performance liquid chromatography.
    Kees F; Strehl E; Seeger K; Seidel G; Dominiak P; Grobecker H
    Arzneimittelforschung; 1981; 31(2):362-5. PubMed ID: 6261772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of the third generation cephalosporins.
    Balant L; Dayer P; Auckenthaler R
    Clin Pharmacokinet; 1985; 10(2):101-43. PubMed ID: 3888488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotaxime levels in ventricular cerebrospinal fluid, determined by bioassay and by high-performance liquid chromatography.
    Brückner O; Collmann H; Borner K
    Chemotherapy; 1983; 29(4):237-43. PubMed ID: 6307602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of serum cefotaxime levels by HPLC with serum bacteriostatic and bactericidal levels.
    Spicer WJ; Franklin JC; Spelman DW
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():109-11. PubMed ID: 6094428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Technic for assaying cefotaxime and desacetylcefotaxime in serum by high performance liquid chromatography].
    Boyer M; Sirot J; Cluzel R
    Pathol Biol (Paris); 1984 Apr; 32(4):285-8. PubMed ID: 6326023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic approach to the determination of cephalosporins in biological fluids by reversed-phase liquid chromatography.
    Rouan MC; Abadie F; Leclerc A; Juge F
    J Chromatogr; 1983 Jun; 275(1):133-44. PubMed ID: 6308024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease.
    Wise R; Wright N; Wills PJ
    Antimicrob Agents Chemother; 1981 Apr; 19(4):526-31. PubMed ID: 6264849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Focus and value of the assay of 5 beta-lactams using high-performance liquid chromatography].
    Jehl F; Monteil H; Minck R
    Pathol Biol (Paris); 1983 May; 31(5):370-4. PubMed ID: 6413937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determinations of cefsulodin and cefotiam in serum and bone marrow blood by high-performance liquid chromatography.
    Yamamura K; Nakao M; Yamada J; Yotsuyanagi T
    J Pharm Sci; 1983 Aug; 72(8):958-60. PubMed ID: 6312012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of moxalactam in human body fluids by liquid chromatographic and microbiological methods.
    Miner DJ; Coleman DL; Shepherd AM; Hardin TC
    Antimicrob Agents Chemother; 1981 Aug; 20(2):252-7. PubMed ID: 6456691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatographic assay of ceftizoxime in sera of normal and uremic patients.
    McCormick EM; Echols RM; Rosano TG
    Antimicrob Agents Chemother; 1984 Mar; 25(3):336-8. PubMed ID: 6326665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High performance liquid chromatographic assay of cefsulodin, cefotiam and cefmenoxime in serum and urine.
    Itakura K; Mitani M; Aoki I; Usui Y
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):622-7. PubMed ID: 6284390
    [No Abstract]   [Full Text] [Related]  

  • 16. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.
    Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S
    Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New spectrophotometric procedure for determining cefotaxime based on derivatization with 1,2-naphthoquinone-4-sulphonate into solid-phase extraction cartridges--application to pharmaceutical and urine samples.
    Martinez LG; Campíns-Falcó P; Sevillano-Cabeza A; Bosch-Reig F
    J Chromatogr B Biomed Sci Appl; 1998 Oct; 718(1):143-51. PubMed ID: 9832371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of human bile and serum levels by high pressure liquid chromatography after administration of latamoxef or cefotaxime.
    Krausse R; Ullmann U; Brandstetter G; Kratochvil P
    Arzneimittelforschung; 1984; 34(12):1787-91. PubMed ID: 6099130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of cefotaxime in human serum by high performance liquid chromatography (HPLC)].
    Li F; Guo L
    Se Pu; 1997 Nov; 15(6):512-4. PubMed ID: 15739335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefotaxime: sites and pathway of metabolic conversion.
    Macdonald CM; McDonald A; Fromson JM; Coombes JD
    Arzneimittelforschung; 1984; 34(12):1729-35. PubMed ID: 6099127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.